This image is of a spacer graphic
NHF Face Book NHF Twitter
+ Login to my NHF
+ NHF Membership
+ Donate to NHF
+ Chapter Center
+ Hechos y Respuestas Rápidas
+ Ethics Advisory Committee
This image is of a spacer graphic
-Researchers and Healthcare Providers
 Research Grants Program
-Medical and Scientific Advisory Council
 Recent Recommendations
 What is MASAC?
 All MASAC Recommendations
 MASAC Members
 Nursing Working Group
 Social Work Working Group
 Physical Therapy Working Group
 Comprehensive Medical Care - Hemophilia Treatment Centers
 Cell Based Coagulation Animation
 Rare Bleeding and Clotting Disorders Resource Room
 The Partners in Bleeding Disorders Education Program
 NHF/Novo Nordisk HANDI Library



MASAC Recommendation #119- MASAC Recommendation Regarding Post HIV-Exposure Chem

MASAC Recommendation #119

MASAC Recommendation Regarding Post HIV-Exposure Chemoprophylaxis

The following recommendation was approved by the Medical and Scientific Advisory Council (MASAC) on May 31, 2001, and adopted by the NHF Board of Directors on June 9, 2001.

When a sexual or nonsexual household exposure to HIV has occurred, at present it is widely recommended that antiretroviral treatment begin promptly, preferably within a few hours of exposure. Therefore, MASAC recommends that if such an exposure occurs, individuals should immediately go to an emergency room or a physician who has expertise in management of HIV exposure. Although HTC staff are available to provide counseling, individuals should not wait to consult with the HTC staff before seeking emergency care, since the effectiveness of post-exposure prophylaxis depends on rapid initiation of treatment.

Thus, HTC staff should discuss the risks and benefits of post-exposure prophylaxis with patients and household members in advance of any exposure in order to facilitate decision-making at the time an exposure occurs. HTC staff should also provide names and addresses of physicians and emergency rooms offering appropriate care in order to facilitate quick access to care.

Centers for Disease Control and Prevention. Management of possible sexual, injecting-drug use, or other non-occupational exposure to HIV, including considerations related to antiretroviral therapy. MMWR 1998;47(RR-17):1-14.

Chapters: Please distribute to your membership.

Physicians: Please distribute this information to all providers who treat persons with hemophilia and related bleeding disorders.